(Rac)-NMDAR antagonist 1, 99%

(Rac)-NMDAR antagonist 1

(Rac)-PT2399, 99%

(Rac)-PT2399

(RS)-Butyryltimolol, 99%

(RS)-Butyryltimolol

(S)-(+)-MT-45 hydrochloride, 99%

(S)-(+)-MT-45 hydrochloride

(S)-3'-amino Blebbistatin, 99%

(S)-3'-amino Blebbistatin

(S)-3'-hydroxy Blebbistatin, 99%

(S)-3'-hydroxy Blebbistatin

(S)-3-Hydroxyisobutyric acid, 99%

(S)-3-Hydroxyisobutyric acid

(S)-3-羟基正丁酸钠, ≧98%

(S)-(+)-3-Hydroxybutyric acid sodium salt

(S)-4-((S)-2-氨基丙酰胺基)-5-(((S)-3-羧基-1-((羧甲基)氨基)-1-氧代丙烷-2-基)氨基)-5-氧代戊酸, ≥99.9%

4-[(2-Amino-1-hydroxypropylidene)amino]-5-(_{3-carboxy-1-[(carboxymethyl)imino]-1-hydroxypropan-2-yl}imino)-5-hydroxypentanoic acid

(S)-4-氨基-5-己烯酸,

S(+)-γ-Vigabatrin

(S)-Ceralasertib, 99%

(S)-Ceralasertib

(S)-Desoxy-D2PM hydrochloride, 99%

(S)-Desoxy-D2PM hydrochloride ((S)-2-Diphenylmethylpyrrolidine)

(S)-Duloxetine D3 hydrochloride, ≥99%

Duloxetine D3 hydrochloride

(S)-GNE-140, 99%

(S)-GNE-140

(S)-KT109, 99%

(S)-KT109

(S)-Mapracorat, 99%

(S)-Mapracorat

(S)-N-(1-(3,4-Difluorophenyl)ethyl)-1H-indazole-3-carboxamide, ≥99%

VPC-80051 racemate

(1R,3R,5R)-rel-2-氮杂双环[3.1.0]己烷-3-羧酸盐酸盐, 98%

(1R,3R,5R)-rel-2-azabicyclo[3.1.0]hexane-3-carboxylic acid hydrochloride

(1R,4R)-氧代-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯, 99%

tert-Butyl (1R,4R)-5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

(1S)- 6-溴-1-(1,1-二甲基乙基亚磺酰胺基)-1,3-二氢螺[茚-2,4'-哌啶]-1'-羧酸叔丁酯, 98%

(1S)-tert-Butyl 6-bromo-1-(1,1-dimethylethylsulfinamido)-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate